Taisho Pharmaceutical and the Adoption of Nanobody Technologies in...

heeft een bestand toegevoegd Health

2024-08-20 08:51:01 -

Taisho Pharmaceutical and the Adoption of Nanobody Technologies in Asia

What are the Primary Challenges Pharmaceutical and Biotechnology Companies Face in Developing and Commercializing Nanobody-Based Therapeutics? Developing and commercializing nanobody-based therapeutics presents significant challenges for pharmaceutical and biotechnology companies. These include the complexity of nanobody production, the need for specialized expertise, and the high costs...

0 Reacties 0 aandelen 356 Views 0 voorbeeld